Designed to automate best choices for consumers as they shop for nutrients, supplements, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, all controlled by user preferences to empower consumers with a practical tool to optimize health and maximize prevention. HolGenTech presented on stage and throughout the conference in the HolGenTech booth.

The PGA uses a device’s bar code reader to capture product ingredient information and respond with personalized screens of recommendation advice and ratings that display on a scale of -10 to +10, corresponding to analysis of integrated data from multiple sources. The PGA user can automatically and immediately identify the personalized prevention efficacy of any product under consideration, as long as the product has a bar code for ingredients. Consumers are equipped to make quick, yet thorough, product comparisons that take into consideration personal health preferences and genomic information with special attention to a disease, syndrome, or health condition they wish to improve. See the YouTube of the HolGenTech PGA demonstration: “Shop for Your Life”.

“A Genome Based Economy is upon us. Soon, awareness of our genome will allow us to use our genome to live in a way that constantly promotes personal health and well being. As we are aware of our genome, we realize that the genome is not our destiny, but rather it is affected by our choices. In the HolGenTech genome computing architecture we perform the analysis and provide the user tools to discover and make the best genomic and personal choices,” said HolGenTech founder Dr. Andras Pellionisz. “Through the HolGenTech genome computing architecture, we can provide answers as consumers respond to the compelling new paradigm and its imperative: Ask what you can do for your genome!”

The HolGenTech PGA illustrates the practical application of the genome, emphasizing how personal genome analysis can be used as a tool for an individual to pursue all they can do to affect their genome. Disease prevention—or health—hinges on optimizing epigenomic pathways through foods, food additives, vitamins, cosmetics, chemicals, and environments to best fit or fix one’s genome. The HolGenTech genome computing architecture—where the PGA represents a mobile component—utilizes high performance parallel computing for genome analysis to search for both conventional structural variants and proprietary search of fractal defects, making the genome practically usable for consumers who want to make their best choices for living.

HolGenTech featured its proprietary genome computing architecture in demonstrations of the PGA mobile application and the Personal Genome Computer (PGC). Also featured in the portfolio is a mobile application for Alzheimer patient tracking, ALZtrek, which utilizes a smartphone's GPS to track the whereabouts of early stage Alzheimer patients.

HolGenTech is presently engaged in securing Series A or angel funding for a rapid ignition to ramp up implementation of the genome computing architecture.

Press Release by PRWeb See original here

HolGenTech Demonstrates first-ever PDA Combination with High Performance Genome Computing at Boston Consumer Genetics Conference

See Press Release in HoloGenomics News

June 19, 2009

A stunned audience embraced the Genome Based Economy when HolGenTech Founder Dr. Andras Pellionisz debuted the first-ever consumer application for genome computing architected with High Performance hybrid Genome PC combined with a Personal Digital Assistant at the Consumer Genetics Conference in Boston on June 10. Affecting individual choices and creating new awareness and understanding of how the world around us impacts the one within us, the personal genome used by PDA presented a new vision of customers tooling up for the future imposed on us by breakthrough genomics and computing.

Sunnyvale, CA (PRWEB) June 19, 2009 -- The Google Phone demonstration introduced the imminent reality of the Genome Based Economy, as presented by HolGenTech Founder Dr. Andras Pellionisz at the "first ever" Consumer Genetics Conference in Boston the morning of June 10. Dr. Pellionisz demonstrated use of PDA for customers at the Consumer Genetics Conference in Boston in the morning of June 10. Within hours, Illumina's CEO Jay Flatley featured a different business model application for personal genomes in the Apple iPhone. The envisioned screenshots of handheld device applications intended for personal genomes stunned the audience of approximately 400 with a view into how practical applications of our personal genomes will change everything. Dr. Pellionisz illuminated the potential of the personal genome when applied to shopping in the Genome Based Economy.

Using the Google Phone's built-in bar code reader, Dr. Pellionisz demonstrated how personal genome computing can detect genome-friendly and genome-supportive products from foods to cosmetics to building materials and beyond. In the envisioned application, the PDA user was assumed to have a genomic proclivity to Parkinson's disease. The demonstration leveraged the Google Phone's bar code reader to capture product information and a product rating scale to identify the prevention efficacy of any product under consideration. The consumer is equipped to make immediate product comparisons based on both personal health-preferences and genomic information with special consideration of the disease or syndrome of concern.

The HolGenTech Google Phone demonstration illustrated practical application of the personal genome, emphasizing how Personal Genome Analysis can be used as a tool for an individual to pursue Personalized Consumer Activity based on one's DNA. The demonstration elucidated how disease prevention--or health--hinges on optimizing epigenomic pathways through foods, food additives, vitamins, cosmetics, chemicals, and environments to best fit or fix one's genome. In a completely different and contrasting model, Illumina's iPhone demonstration focused on reading one's genome information for the purpose of comparison to others'.

The Personal Genome Computer -- a tool for the Genome Based Economy

"The Personal Genome Computer is the catalyst tool for the Genome Based Economy. We look to chip-makers Intel, AMD, Xilinx, and Altera, and to integrators like HP, Dell, DRC, and even IT giants like Google and Microsoft, for next developments in parallel processing to produce HPC desktop- and server-lines as the IT infrastructure of the Genome Based Economy," said Dr. Andras Pellionisz. "As high performance computing, custom algorithms and post-ENCODE genomics align, more personalized medicine and health care, wellness, prevention, and DNA-informed personal and lifestyle choices are realized. With affordable access to and utility of our personalized genome we can experience personalized everything from health care to food to clothing to housing and environmental choices, even to friends....everything suited to one's personal genome."

In the HolGenTech presentation in Boston, Pellionisz outlined the unprecedented computing-challenge posed by the oncoming avalanche of affordable full genome sequences which require in-depth analysis to be useful. Today "Direct-to-Customers" genome testing companies, such as DeCodeMe, 23andME, and Navigenics, rely on Illumina/Affymetrix microarray-technology to interrogate up to 1.6 million SNP-s (single nucleotide polymorphisms, point mutations of the 6.2 billion A,C,T,G letters/amino acid bases of human DNA), though the field of genomics is already beyond SNP-s and awaits the next developments in nano-sequencing technology, which promise affordable and readily available personal genomes by the second half of 2009.

Landmark Principles in Action

The Consumer Genetics Conference coincides with the second anniversary of the epoch-making release of ENCODE results, when mastermind Francis Collins, the most prominent keynote speaker at the Boston conference, declared, "the scientific community had to re-think long-held fundamentals." In response to Francis Collins' direct call, Dr. Pellionisz published one year ago the landmark paper The Principle of Recursive Genome Function. Emerging from the conference, a new consensus demands advanced computational mechanisms to search for much more complex (mal)formations of full DNA sequences. While the new Illumina microarray extends utility up to 4 million points and includes the ability to spot over 10 thousand "copy number variations," Pellionisz' research points to the problem of algorithmic, recursive genome regulation, where genome regulation derailments require intricate searches for cancer-stopping microRNA-s, silent mutations, repeat motifs and fractal defects.